Anna Tesei Biosciences Laboratory Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Biography Publications Institution JoVE Articles Anna Tesei has not added a biography. If you are Anna Tesei and would like to personalize this page please email our Author Liaison for assistance. Publications DNA Ploidy and S-phase Fraction Analysis in Peritoneal Carcinomatosis from Ovarian Cancer: Correlation with Clinical Pathological Factors and Response to Chemotherapy OncoTargets and Therapy. 2017 | Pubmed ID: 29033584 Preclinical Evidence of Multiple Mechanisms Underlying Trastuzumab Resistance in Gastric Cancer Oncotarget. Apr, 2016 | Pubmed ID: 26919099 3D Tumor Spheroid Models for in Vitro Therapeutic Screening: a Systematic Approach to Enhance the Biological Relevance of Data Obtained Scientific Reports. Jan, 2016 | Pubmed ID: 26752500 Cancer Multicellular Spheroids: Volume Assessment from a Single 2D Projection Computer Methods and Programs in Biomedicine. Feb, 2015 | Pubmed ID: 25561413 Improving Reliability of Live/dead Cell Counting Through Automated Image Mosaicing Computer Methods and Programs in Biomedicine. Dec, 2014 | Pubmed ID: 25438936 Anti-tumor Activity of Fenretinide Complexed with Human Serum Albumin in Lung Cancer Xenograft Mouse Model Oncotarget. Jul, 2014 | Pubmed ID: 25015569 In Vitro Irradiation System for Radiobiological Experiments Radiation Oncology (London, England). Nov, 2013 | Pubmed ID: 24180359 Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models PloS One. 2013 | Pubmed ID: 23667504 Organosulfur Derivatives of the HDAC Inhibitor Valproic Acid Sensitize Human Lung Cancer Cell Lines to Apoptosis and to Cisplatin Cytotoxicity Journal of Cellular Physiology. Oct, 2012 | Pubmed ID: 22212895 Low-dose Taxotere Enhances the Ability of Sorafenib to Induce Apoptosis in Gastric Cancer Models Journal of Cellular and Molecular Medicine. Feb, 2011 | Pubmed ID: 20015197 Buscando vías de controlador de adquirir resistencia a la terapia dirigida: sensibilidad restaurar por Gene Knock-down y generación Subclone resistente a los medicamentos Chiara Arienti1, Sara Pignatta1, Michele Zanoni1, Michela Cortesi1, Alice Zamagni1, Filippo Piccinini2, Anna Tesei1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56583 Cancer Research
Buscando vías de controlador de adquirir resistencia a la terapia dirigida: sensibilidad restaurar por Gene Knock-down y generación Subclone resistente a los medicamentos Chiara Arienti1, Sara Pignatta1, Michele Zanoni1, Michela Cortesi1, Alice Zamagni1, Filippo Piccinini2, Anna Tesei1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 56583 Cancer Research
